Guide summary
Check every medicine by active ingredient against current Saudi rules well before travel. A medicine being prescribed or sold over the counter in the UK does not establish that it may enter Saudi Arabia, and a UK prescription alone does not guarantee clearance. Controlled products may require prior action through the Saudi Food and Drug Authority (SFDA). Obtain detailed clinical documents, carry only the quantity authorised for your circumstances, use original labelled packaging and arrange Saudi clinical follow-up before supplies run low. Never stop, reduce or substitute treatment without the prescriber’s advice.
Start at least several weeks before departure
Make one inventory for everything you intend to carry, not only regular tablets. Include prescription medicines, occasional treatments, over-the-counter products, vitamins, herbal preparations, injections, inhalers, creams, medicated patches, liquids and devices. For each item record:
- brand name and exact active ingredient;
- strength, pharmaceutical form and prescribed dose;
- daily use and total proposed quantity;
- reason for treatment and prescriber;
- storage range and expiry date; and
- whether needles, a pump, batteries or cooling equipment are needed.
Use the active ingredient because brands and formulations differ between countries. Combination products need every ingredient checked. Do not assume a supplement, herbal remedy, sleep aid, strong painkiller or attention or anxiety medicine is low-risk merely because it is familiar in Britain.
Check the legal status with Saudi authorities
GOV.UK warns that some medicines prescribed or bought in the UK are controlled substances in Saudi Arabia and that approval may be needed. Use the live SFDA rules and services, including the Electronic Controlled Drug System (CDS) where applicable. If classification or the correct traveller route is unclear, ask SFDA through its official contact channel and retain the written answer. A travel agent, airline employee, pharmacy forum or social-media post cannot authorise import.
Rules can distinguish controlled or narcotic and psychotropic medicines from other prescriptions, and can treat accompanied baggage differently from postal or express shipments. Do not post a controlled medicine to yourself: SFDA’s personal-use guidance states that narcotic and psychotropic drugs subject to control are not to be transported through express companies or mail. If someone else will carry medicine for the patient, ask what relationship, consent and identity evidence is required.
Prepare a proper clinical document pack
Ask the treating clinician or institution for documents that match the medicine and journey. GOV.UK advises carrying an official prescription, hospital note or GP letter showing the amount prescribed, drug and dosage, doctor’s signature and a clinic or hospital stamp. SFDA guidance may require further detail and sets recency conditions for particular routes.
Ask for a signed and dated report or letter containing:
- the patient’s full name, passport details if the clinician can include them, and date of birth;
- diagnosis or clinical reason, where appropriate;
- generic scientific name, strength and dosage form;
- dose, method of use, treatment duration and quantity needed;
- the prescriber’s name, registration details and contact information;
- the medical institution’s details, signature and stamp; and
- why uninterrupted treatment or equipment is clinically necessary.
Carry originals plus paper and secure digital copies. Make sure the label, prescription, report, permit application and passport spell the patient’s name consistently. If a translation is requested, ask SFDA which language and certification are acceptable rather than choosing a service first.
Use the correct SFDA route
The CDS describes itself as the SFDA-linked platform regulating narcotic and psychotropic substances. Create or use only the official traveller account and follow the current application prompts if your medicine falls within that system.
The broader SFDA personal-use guidance covers medicines and other regulated products arriving with passengers or through shipment. Quantity and evidence rules differ by product and channel. Do not copy a number from an old checklist: calculate the proposed supply from the prescribed dose, then confirm the live limit and whether it is capped by length of stay. Approval, where required, should be obtained before travel—not assumed at the airport.
Pack for inspection and safe use
- Keep medicine in its original pharmacy or manufacturer container with the dispensing label intact.
- Put essential medicine and documents in hand baggage, subject to airline and security rules.
- Separate the amount needed in transit without decanting unlabelled doses.
- Protect glass, sharps and devices, and carry a clinician’s explanation for needles or equipment.
- Check airline rules for liquids, batteries and medical devices on every sector.
- Do not combine supplies belonging to different travellers.
- Keep the SFDA approval or correspondence ready for customs inspection.
Declare items when Saudi customs or another authority requires it. Never conceal, relabel or dispose of medicine in an airport unless directed by an authorised official and it is safe to do so.
Plan cold-chain medicines with professionals
Ask the dispensing pharmacist or manufacturer for the authorised temperature range, permitted excursions and handling instructions. Confirm with the airline whether a medical cool bag, gel packs or device batteries may travel in the cabin. A domestic fridge, ice or an unmonitored luggage hold may damage treatment.
Protect continuity after arrival
GOV.UK states that UK prescriptions are not accepted for dispensing in Saudi Arabia and that prescriptions must be issued by a locally registered and licensed doctor. Before the carried supply runs low, check your insurer’s network and book an appropriate Saudi clinician.
Use the SFDA’s Saudi Drugs Information service as a starting point for registered product information, but let a licensed clinician and pharmacist decide whether an available product is clinically suitable. A matching brand name does not prove identical ingredients or strength. Do not buy from informal sellers or import replacement medicine by courier without confirming the rules.
If the medicine cannot be brought in
Contact the treating clinician promptly. Ask about a medically safe, lawful plan: an alternative, supervised transition, adjusted travel date or handover to a Saudi specialist. Do not stop suddenly, ration doses or substitute an over-the-counter product. If travel is unavoidable, obtain written advice from the clinician and Saudi authority before packing.
Clear limits
This is a planning guide, not medical or legal advice. It does not confirm that any ingredient is permitted, controlled, available, clinically interchangeable or covered by insurance. It does not promise SFDA approval or medicine entry. Classifications, online routes, document recency and quantity limits can change and may depend on medicine, traveller, visa, journey and transport method.
When to get help
Contact SFDA before travel when an ingredient is controlled or unclear, the proposed quantity exceeds the apparent personal-use allowance, another person will carry it, or it will arrive by post or courier. Ask the airline about cabin equipment and cooling; ask the prescriber or pharmacist about treatment and stability. Seek urgent medical care rather than changing treatment yourself if supply is interrupted or symptoms worsen. In Saudi Arabia, use an insurer-approved provider where possible and contact the insurer promptly about treatment arrangements.
Official sources
- GOV.UK: Saudi Arabia health advice
- SFDA: Personal-use permits guidance (PDF)
- SFDA: Personal-use permit conditions and requirements
- SFDA Electronic Controlled Drug System
- SFDA services directory
Recheck the live SFDA route and GOV.UK advice before every journey.